Education
About Us
Working with TipRanks
Follow Us
Innovative Pharmaceutical Biotech Limited (HK:0399)
:0399
RESEARCH TOOLSreports
0399 Stock Chart & Stats
Day’s Range― - ―
52-Week RangeHK$0.15 - HK$0.70
Previous CloseN/A
Volume1.53M
Average Volume (3M)6.15M
Market Cap
HK$420.83M
Enterprise ValueHK$1.49B
Total Cash (Recent Filing)HK$428.00K
Total Debt (Recent Filing)HK$895.34M
Price to Earnings (P/E)36.2
Beta-0.06
Next Earnings
Jun 30, 2025EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)N/A
Shares Outstanding1,845,757,900
10 Day Avg. Volume14,132,593
30 Day Avg. Volume6,153,714
Financial Highlights & Ratios
PEG Ratio<0.01
Price to Book (P/B)-0.38
Price to Sales (P/S)0.00
P/FCF Ratio-17.26
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
Innovative Pharmaceutical Biotech News
PremiumCompany Announcements
Innovative Pharmaceutical Biotech Announces Board and Committee Structure
PremiumCompany Announcements
Innovative Pharmaceutical Biotech Reports Significant Annual Loss
PremiumCompany Announcements
Innovative Pharmaceutical Biotech Schedules Board Meeting for Annual Results
PremiumCompany Announcements
Innovative Pharmaceutical Biotech to Issue New Shares Under General Mandate
PremiumCompany Announcements
Innovative Pharmaceutical Biotech Announces New Share Placement0399 FAQ
What was Innovative Pharmaceutical Biotech Limited’s price range in the past 12 months?
Innovative Pharmaceutical Biotech Limited lowest stock price was HK$0.14 and its highest was HK$0.70 in the past 12 months.
What is Innovative Pharmaceutical Biotech Limited’s market cap?
Innovative Pharmaceutical Biotech Limited’s market cap is HK$420.83M.
When is Innovative Pharmaceutical Biotech Limited’s upcoming earnings report date?
Innovative Pharmaceutical Biotech Limited’s upcoming earnings report date is Jun 30, 2025 which is 8 days ago.
How were Innovative Pharmaceutical Biotech Limited’s earnings last quarter?
Currently, no data Available
Is Innovative Pharmaceutical Biotech Limited overvalued?
According to Wall Street analysts Innovative Pharmaceutical Biotech Limited’s price is currently Overvalued.
Does Innovative Pharmaceutical Biotech Limited pay dividends?
Innovative Pharmaceutical Biotech Limited does not currently pay dividends.
What is Innovative Pharmaceutical Biotech Limited’s EPS estimate?
Innovative Pharmaceutical Biotech Limited’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Innovative Pharmaceutical Biotech Limited have?
Innovative Pharmaceutical Biotech Limited has 1,845,757,900 shares outstanding.
What happened to Innovative Pharmaceutical Biotech Limited’s price movement after its last earnings report?
Currently, no data Available
Which hedge fund is a major shareholder of Innovative Pharmaceutical Biotech Limited?
Currently, no hedge funds are holding shares in HK:0399
Innovative Pharmaceutical Biotech Stock Smart Score
Neutral
1
2
3
4
5
6
7
8
9
10
Technicals
SMA
Positive
20 days / 200 days
Momentum
5.04%
12-Months-Change
Fundamentals
Return on Equity
―
Trailing 12-Months
Asset Growth
-0.24%
Trailing 12-Months
Company Description
Innovative Pharmaceutical Biotech Limited
Innovative Pharmaceutical Biotech Limited, an investment holding company, engages in the trading of beauty equipment and products in the People's Republic of China and Hong Kong. The company operates in two segments, Trading of Beauty Products, and Research and Development. It is also involved in the securities investment; research, development, and commercialization of oral insulin products; distribution of bio-industrial products; and provision of genetic testing services. The company was formerly known as United Gene High-Tech Group Limited and changed its name to Innovative Pharmaceutical Biotech Limited in September 2015. Innovative Pharmaceutical Biotech Limited is headquartered in Sheung Wan, Hong Kong.
Technical Analysis
Natural Beauty Bio-Technology
―
EC Healthcare
―
Giant Biogene Holding Co. Ltd.
―
Nanjing Sinolife United Co., Ltd. Class H
―
Blue Moon Group Holdings Ltd.
―